| Market Cap | 4.69B | P/E | 40.63 | EPS this Y | 30.70% | Ern Qtrly Grth | -5.20% |
| Income | 126.57M | Forward P/E | 22.27 | EPS next Y | 11.10% | 50D Avg Chg | 7.00% |
| Sales | 1.27B | PEG | 1.81 | EPS past 5Y | 7.00% | 200D Avg Chg | 12.00% |
| Dividend | N/A | Price/Book | 5.71 | EPS next 5Y | 12.00% | 52W High Chg | -2.00% |
| Recommedations | 2.10 | Quick Ratio | 1.55 | Shares Outstanding | 50.79M | 52W Low Chg | 38.00% |
| Insider Own | 0.76% | ROA | 6.12% | Shares Float | 50.37M | Beta | 0.36 |
| Inst Own | 101.59% | ROE | 14.72% | Shares Shorted/Prior | 2.24M/2.18M | Price | 92.63 |
| Gross Margin | 54.10% | Profit Margin | 9.97% | Avg. Volume | 294,111 | Target Price | 105.57 |
| Oper. Margin | 16.04% | Earnings Date | May 9 | Volume | 201,482 | Change | 0.40% |
Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system, and Donor360. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot including collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
| Barrington Research | Outperform | Apr 12, 24 |
| Barrington Research | Outperform | Feb 13, 24 |
| Barrington Research | Outperform | Nov 3, 23 |
| Citigroup | Neutral | Oct 2, 23 |
| Barrington Research | Outperform | Aug 9, 23 |
| Barrington Research | Outperform | May 12, 23 |
| Morgan Stanley | Equal-Weight | May 12, 23 |
| JMP Securities | Market Outperform | May 12, 23 |
| Morgan Stanley | Equal-Weight | Feb 8, 23 |
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Simon, Christopher | President & CEO President & CEO | Jun 29 | Option | 28.62 | 196,746 | 5,630,871 | 414,113 | 06/30/23 |
| Llorens Josep | EVP, Global Manufact.. EVP, Global Manufacturing | Jan 23 | Sell | 90 | 2,391 | 215,190 | 17,234 | 01/25/23 |
| Llorens Josep | EVP, Global Manufact.. EVP, Global Manufacturing | Jan 23 | Option | 56.57 | 2,391 | 135,259 | 19,625 | 01/25/23 |
| Basil Michelle L | EVP and General Coun.. EVP and General Counsel | Sep 19 | Option | 45.55 | 8,688 | 395,738 | 44,083 | 09/21/22 |
| Basil Michelle L | EVP and General Coun.. EVP and General Counsel | Sep 19 | Sell | 78.36 | 11,448 | 897,065 | 32,635 | 09/21/22 |
| Miller Laurie A. | SVP, Human Resources SVP, Human Resources | Sep 19 | Sell | 76.25 | 212 | 16,165 | 12,697 | 09/21/22 |
| Miller Laurie A. | SVP, Human Resources SVP, Human Resources | May 16 | Sell | 56.1 | 31 | 1,739 | 10,232 | 05/18/22 |
| Llorens Josep | EVP, Global Manufact.. EVP, Global Manufacturing | May 16 | Sell | 56.1 | 107 | 6,003 | 14,413 | 05/18/22 |
| Goldstein Dan | VP, Corporate Contro.. VP, Corporate Controller | May 16 | Sell | 56.1 | 50 | 2,805 | 4,004 | 05/18/22 |
| Basil Michelle L | EVP and General Coun.. EVP and General Counsel | May 20 | Sell | 55.19 | 220 | 12,142 | 39,047 | 05/20/21 |